Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,034 | 470 | 321 | 515 | 310 |
| Cost of Goods | 841 | 339 | 812 | 265 | 127 |
| Gross Profit | 193 | 131 | -491 | 250 | 182 |
| Operating Expenses | 2,342 | 2,365 | 2,988 | 3,297 | 3,722 |
| Operating Income | -2,149 | -2,234 | -3,479 | -3,047 | -3,540 |
| Other Income | 153 | 136 | -24 | -4,823 | 64 |
| Pre-tax Income | -1,996 | -2,098 | -3,503 | -7,870 | -3,476 |
| Income Tax | 2 | 3 | 7 | N/A | N/A |
| Net Income Continuous | -1,998 | -2,101 | -3,510 | -7,870 | -3,476 |
| Net Income | $-1,998 | $-2,101 | $-3,510 | $-7,870 | $-3,476 |
| EBITDA(a) | $-2,000 | $-2,087 | $-3,331 | $-7,716 | $-3,322 |